Table 3.
NC | T | Mel 15 | Mel 30 | NR | |
---|---|---|---|---|---|
WBCs(×103/μl) | 8.75 ± 1.19 | 5.45 ± 2.09 | 11.91 ± 1.32b**** | 14.13 ± 2.78b**** | 9.525 ± 2.00b* |
LYM (%) | 70.12 ± 7.82 | 79.23 ± 7.44 | 75.77 ± 4.19 | 70.52 ± 9.36 | 67.67 ± 11.65 |
MON (%) | 4.55 ± 2.20 | 4.433 ± 2.12 | 7.117 ± 2.38 | 5.1 ± 2.18 | 5.75 ± 1.86 |
NEU (%) | 19.5 ± 4.33 | 5.633 ± 1.09a** | 13.73 ± 2.24 | 21.17 ± 8.98b** | 22.85 ± 9.88b*** |
EOS (%) | 1.15 ± 0.23 | 1.22 ± 0.26 | 3.23 ± 1.55b* | 3.48 ± 1.43b* | 3.65 ± 1.36b** |
BAS (%) | 0.08 ± 0.04 | 9.483 ± 4.41a**** | 0.15 ± 0.05b**** | 0.1 ± 0.0b**** | 0.08 ± 0.04b**** |
RBCs) × 106/μl) | 9.033 ± 0.852 | 7.755 ± 0.26 a** | 7.90 ± 0.22 | 7.952 ± 0.69 | 7.305 ± 0.34 |
Hb (g/dl) | 15.18 ± 0.80 | 13.03 ± 0.89a** | 14.88 ± 0.32b** | 15.17 ± 0.74b** | 14.5 ± 1.17b* |
Hct (%) | 48.78 ± 2.67 | 40.67 ± 2.28a*** | 48.22 ± 1.90b** | 49.17 ± 2.47b*** | 47.6 ± 4.46b** |
MCV (ƒL) | 65.3 ± 3.31 | 52.4 ± 1.69a**** | 61.03 ± 2.11b** | 62.12 ± 3.81b*** | 65.23 ± 5.48b**** |
MCH (pg) | 20.32 ± 0.79 | 17.52 ± 0.65a*** | 18.85 ± 0.35 | 19.12 ± 1.15b* | 19.85 ± 1.27b** |
MCHC (g/dL) | 31.13 ± 0.41 | 33.37 ± 0.38a**** | 30.90 ± 0.99b**** | 30.83 ± 0.36b**** | 30.5 ± 0.97b**** |
PLT (×103/μl) | 777 ± 68.9 | 427.5 ± 146.5a** | 827.8 ± 76.3b*** | 794.5 ± 130.6b** | 607.7 ± 246.4 |
RDW-CV (%) | 18.22 ± 2.1 | 24.35 ± 2.1a**** | 27.1 ± 1.84 | 28.65 ± 1.93b** | 24.75 ± 1.56 |
Results are expressed as mean ± SD (n = 6)
WBCs White Blood Cells; Lym lymphocytes; Mon: Monocytes; Neu Neutrophils; EOS Eosinophils; Bas Basophils; RBCs Red Blood Cells; Hb Hemoglobin; Hct Hematocrit; MCV Mean corpuscular volume; MCH Mean Corpuscular Hemoglobin; MCHC Mean corpuscular Hemoglobin concentration; PLT platelets; RDW-CV Red blood cell distribution width - Coefficient of Variation
NC control, T Toxic, Mel15 Melittin15μg, Mel 30 Melittin30μg, NR Normal recovery
*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. a: significant Vs NC group, b: significant Vs T group